Publikation:

Elevated expression of the tyrosine phosphatase SHP-1 defines a subset of high-grade breast tumors

Lade...
Vorschaubild

Dateien

Zu diesem Dokument gibt es keine Dateien.

Datum

2009

Autor:innen

Insabato, Luigi
Quarto, Maria
Zannetti, Antonella
Tolino, Fabio
de Mauro, Gaia
Cerchia, Laura
Riccio, Patrizia
Baumhoer, Daniel
Condorelli, Gerolama
et al.

Herausgeber:innen

Kontakt

ISSN der Zeitschrift

Electronic ISSN

ISBN

Bibliografische Daten

Verlag

Schriftenreihe

Auflagebezeichnung

URI (zitierfähiger Link)
DOI (zitierfähiger Link)
ArXiv-ID

Internationale Patentnummer

Angaben zur Forschungsförderung

Projekt

Open Access-Veröffentlichung
Core Facility der Universität Konstanz

Gesperrt bis

Titel in einer weiteren Sprache

Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published

Erschienen in

Oncology. Karger. 2009, 77(6), pp. 378-384. ISSN 0030-2414. eISSN 1423-0232. Available under: doi: 10.1159/000276765

Zusammenfassung

Objectives: Protein tyrosine phosphatases are key regulators of intracellular signaling that contribute to determining cancer cell growth, which thus makes them attractive targets for therapeutic and diagnostic agents. SHP-1 phosphotyrosine phosphatase is rarely expressed in epithelial tumor cells, but expression has been found in several breast cancer cell lines and tumors. To determine the potential significance of SHP-1 as a prognostic marker in the clinical setting, we examined SHP-1 protein expression in breast tumors. Methods: We analyzed SHP-1 expression by immunohistochemistry in a breast tissue microarray composed of 2,081 cores, either alone or in combination with known prognostic markers. Results: Our data showed that SHP-1 expression was confined to a well-defined subset of high-grade tumors characterized by unique biological parameters. SHP-1 expression correlated directly with expression of the tyrosine kinase receptor HER-2 and inversely with expression of the estrogen receptor, while it was weakly associated with Bcl-2 expression. Conclusions: Levels of SHP-1 were correlated with conventional pathologic parameters of tumor aggressiveness and were associated with reduced patient survival, suggesting that elevated expression of SHP-1 is a common molecular abnormality in a defined subset of breast tumors and might be used in routine diagnosis to identify patients with high-risk tumors.

Zusammenfassung in einer weiteren Sprache

Fachgebiet (DDC)
570 Biowissenschaften, Biologie

Schlagwörter

Breast cancer, Tissue microarray, Tyrosine phosphatase, Clinical setting, SHP-1

Konferenz

Rezension
undefined / . - undefined, undefined

Forschungsvorhaben

Organisationseinheiten

Zeitschriftenheft

Zugehörige Datensätze in KOPS

Zitieren

ISO 690INSABATO, Luigi, Ivano AMELIO, Maria QUARTO, Antonella ZANNETTI, Fabio TOLINO, Gaia DE MAURO, Laura CERCHIA, Patrizia RICCIO, Daniel BAUMHOER, Gerolama CONDORELLI, 2009. Elevated expression of the tyrosine phosphatase SHP-1 defines a subset of high-grade breast tumors. In: Oncology. Karger. 2009, 77(6), pp. 378-384. ISSN 0030-2414. eISSN 1423-0232. Available under: doi: 10.1159/000276765
BibTex
@article{Insabato2009Eleva-57135,
  year={2009},
  doi={10.1159/000276765},
  title={Elevated expression of the tyrosine phosphatase SHP-1 defines a subset of high-grade breast tumors},
  number={6},
  volume={77},
  issn={0030-2414},
  journal={Oncology},
  pages={378--384},
  author={Insabato, Luigi and Amelio, Ivano and Quarto, Maria and Zannetti, Antonella and Tolino, Fabio and de Mauro, Gaia and Cerchia, Laura and Riccio, Patrizia and Baumhoer, Daniel and Condorelli, Gerolama}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/57135">
    <dc:contributor>Condorelli, Gerolama</dc:contributor>
    <dcterms:title>Elevated expression of the tyrosine phosphatase SHP-1 defines a subset of high-grade breast tumors</dcterms:title>
    <dc:contributor>Amelio, Ivano</dc:contributor>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dc:rights>terms-of-use</dc:rights>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/57135"/>
    <dc:contributor>Baumhoer, Daniel</dc:contributor>
    <dc:contributor>de Mauro, Gaia</dc:contributor>
    <dc:contributor>Tolino, Fabio</dc:contributor>
    <dc:contributor>Riccio, Patrizia</dc:contributor>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-04-01T08:01:55Z</dcterms:available>
    <dc:language>eng</dc:language>
    <dcterms:abstract xml:lang="eng">Objectives: Protein tyrosine phosphatases are key regulators of intracellular signaling that contribute to determining cancer cell growth, which thus makes them attractive targets for therapeutic and diagnostic agents. SHP-1 phosphotyrosine phosphatase is rarely expressed in epithelial tumor cells, but expression has been found in several breast cancer cell lines and tumors. To determine the potential significance of SHP-1 as a prognostic marker in the clinical setting, we examined SHP-1 protein expression in breast tumors. Methods: We analyzed SHP-1 expression by immunohistochemistry in a breast tissue microarray composed of 2,081 cores, either alone or in combination with known prognostic markers. Results: Our data showed that SHP-1 expression was confined to a well-defined subset of high-grade tumors characterized by unique biological parameters. SHP-1 expression correlated directly with expression of the tyrosine kinase receptor HER-2 and inversely with expression of the estrogen receptor, while it was weakly associated with Bcl-2 expression. Conclusions: Levels of SHP-1 were correlated with conventional pathologic parameters of tumor aggressiveness and were associated with reduced patient survival, suggesting that elevated expression of SHP-1 is a common molecular abnormality in a defined subset of breast tumors and might be used in routine diagnosis to identify patients with high-risk tumors.</dcterms:abstract>
    <dcterms:issued>2009</dcterms:issued>
    <dc:creator>Quarto, Maria</dc:creator>
    <dc:creator>Zannetti, Antonella</dc:creator>
    <dc:creator>Cerchia, Laura</dc:creator>
    <dc:contributor>Zannetti, Antonella</dc:contributor>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-04-01T08:01:55Z</dc:date>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:contributor>Quarto, Maria</dc:contributor>
    <dc:contributor>Cerchia, Laura</dc:contributor>
    <dc:creator>Baumhoer, Daniel</dc:creator>
    <dc:creator>Condorelli, Gerolama</dc:creator>
    <dc:creator>Riccio, Patrizia</dc:creator>
    <dc:creator>Insabato, Luigi</dc:creator>
    <dc:creator>Amelio, Ivano</dc:creator>
    <dc:contributor>Insabato, Luigi</dc:contributor>
    <dc:creator>Tolino, Fabio</dc:creator>
    <dc:creator>de Mauro, Gaia</dc:creator>
  </rdf:Description>
</rdf:RDF>

Interner Vermerk

xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter

Kontakt
URL der Originalveröffentl.

Prüfdatum der URL

Prüfungsdatum der Dissertation

Finanzierungsart

Kommentar zur Publikation

Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Nein
Begutachtet
Ja
Diese Publikation teilen